Pyrimidine-sulfamides and their use as endothelian receptor antagonist

Details for Australian Patent Application No. 2003285321 (hide)

Owner Actelion Pharmaceuticals Ltd

Inventors Clozel, Martine; Bolli, Martin; Weller, Thomas; Fischli, Walter; Boss, Christoph

Agent A J Park

Pub. Number AU-B-2003285321

PCT Number PCT/EP2003/0125

PCT Pub. Number WO2004/050640

Priority PCT/EP02/13601 02.12.02 EP

Filing date 10 November 2003

Wipo publication date 23 June 2004

Acceptance publication date 8 April 2010

International Classifications

C07D 239/52 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/46 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/56 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): PCT/EP02/13601 02.12.02 EP

29 July 2004 Application Open to Public Inspection

  Published as AU-B-2003285321

8 April 2010 Application Accepted

  Published as AU-B-2003285321

5 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003285322-METHOD FOR PRODUCING TERTBUTANOL BY MEANS OF REACTIVE RECTIFICATION

2003285320-VACCINE